Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Alfentanil Dose for Skull Pin Fixation Under SPI Monitoring
NCT06563297Phase 4Not yet recruiting
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Aug 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alfentanil in procedural pain, sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
alfentanil
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT06563297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06563297.